✦ LIBER ✦

Successful treatment of active Crohn's disease with oral dehydroepiandrosterone (DHEA): An open controlled pilot trial

✍ Scribed by Andus, Tilo; Klebl, Frank; Rogler, Gerhard; Bregenzer, Nicole; Schoelmerich, Juergen; Straub, Rainer H.

Book ID: 124147251
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 194 KB
Volume: 120
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(08)81379-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Successful treatment of refractory ulcer

Successful treatment of refractory ulcerative colitis with dehydroepiandrosterone (DHEA) — An open controlled pilot trial

✍ Tilo Andus; Frank Klebl; Gerhard Rogier; Jurgen Scholmerich; Rainer H. Straub 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 173 KB

A controlled trial comparing ciprofloxac

A controlled trial comparing ciprofloxacin with mesalazine for the treatment of active Crohn’s disease

✍ Jean-Frédéric Colombel; Marc Lémann; Michel Cassagnou; Yoram Bouhnik; Bernard Du 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 50 KB

Polymeric Diet Alone Versus Corticostero

Polymeric Diet Alone Versus Corticosteroids in the Treatment of Active Pediatric Crohn’s Disease: A Randomized Controlled Open-Label Trial

✍ Borrelli, Osvaldo; Cordischi, Letizia; Cirulli, Manuela; Paganelli, Massimiliano 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 242 KB

Oral pentasa in the treatment of active

Oral pentasa in the treatment of active Crohn?s disease: A meta-analysis of double-blind, placebo-controlled trials

✍ HANAUER, S 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 132 KB

Randomized, double-blind, placebo-contro

Randomized, double-blind, placebo-controlled trial of the oral interleukin-12/23 inhibitor apilimod mesylate for treatment of active Crohn's disease

✍ Bruce E. Sands; Eric W. Jacobson; Thomas Sylwestrowicz; Ziad Younes; Gerald Dryd 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 349 KB 👁 1 views

## Background: Interleukin-12 (il-12) and interleukin-23 (il-23) are inflammatory cytokines linked to the th-1 and th-17 phenotypes associated with crohn's disease (cd). we investigated the activity and safety of apilimod mesylate (formerly sta-5326), an oral il-12 and il-23 inhibitor, in patients

Antibiotic treatment of active Crohn's d

Antibiotic treatment of active Crohn's disease: Results of a multicentre, double blind, randomised, placebo-controlled trial with rifaximin (Grace 01)

✍ M.L. Seribano; H. Lochs; M. Campieri; G.C. Sturniolo; F. Castiglione; M. Cottone 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 400 KB